Cláudia dos Santos Cople-Rodrigues

Cláudia dos Santos Cople-Rodrigues

Auto-generated profile, based on publicly available information

Cláudia dos Santos Cople-Rodrigues

Nutrition Institute, Rio de Janeiro State University, Rio de Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
JMJuliana Mendonca
Juliana Mendonca
CCCláudia Dos Santos Cople-Rodrigues
Cláudia Dos Santos Cople-Rodrigues
JCJessyca Dias Do Amaral Cardoso
Jessyca Dias Do Amaral Cardoso
ASAndrea Ribeiro Soares
Andrea Ribeiro Soares
MFMarcos Kneip Fleury
Marcos Kneip Fleury
MCMarta Citelli
Marta Citelli
Dietary iron requirements in patients with sickle cell disease (SCD) remain unclear. SCD is a neglected hemoglobinopathy characterized by intense erythropoietic activity and anemia. Hepcidin is the hormone mainly responsible for iron homeostasis and intestinal absorption. Intense erythropoietic activity and anemia may reduce hepcidin transcription. By contrast, iron overload and inflammation may induce it. Studies on SCD have not evaluated the role of hepcidin in the presence and absence of iron overload. We aimed to compare serum hepcidin concentrations among individuals with sickle cell anemia, with or without iron overload, and those without the disease. Markers of iron metabolism and erythropoietic activity such as hepcidin, ferritin, and growth differentiation factor 15 were evaluated. Three groups participated in the study: the control group, comprised of individuals without SCD (C); those with the disease but without iron overload (SCDw); and those with the disease and iron overload (SCDio). Results showed that hepcidin concentration was higher in the SCDio > C > SCDw group. These data suggest that the dietary iron intake of the SCDio group should not be reduced as higher hepcidin concentrations may reduce the intestinal absorption of iron.

13 September 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
EDEmília Delesderrier
Emília Delesderrier
CCCláudia S. Cople-Rodrigues
Cláudia S. Cople-Rodrigues
JMJuliana Mendonca
Juliana Mendonca
MFMarcos Kneip Fleury
Marcos Kneip Fleury
FBFlavia dos Santos Barbosa Brito
Flavia dos Santos Barbosa Brito
MCMarta Citelli
Marta Citelli
Sickle cell disease (SCD) is a genetic hemoglobinopathy characterized by chronic hemolysis. Chronic hemolysis is promoted by increased oxidative stress. Our hypothesis was that some antioxidant micronutrients (retinol, tocopherol, selenium, and zinc) would be determinant factors of the degree of hemolysis in SCD patients. We aimed to investigate the nutritional adequacy of these antioxidants and their relationships to hemolysis. The study included 51 adult SCD patients regularly assisted in two reference centers for hematology in the State of Rio de Janeiro, Brazil. Serum concentrations of retinol, alpha-tocopherol, selenium, and zinc were determined by high-performance liquid chromatography or atomic absorption spectrometry. Hematological parameters (complete blood count, reticulocyte count, hemoglobin, direct and indirect bilirubin, total bilirubin, lactate dehydrogenase) and inflammation markers (leukocytes and ultra-sensitive C-reactive protein) were analyzed. A linear regression model was used to test the associations between the variables. Most patients presented selenium deficiency and low selenium consumption. Linear regression analysis showed that selenium is the main determinant of hemolysis among the antioxidant nutrients analyzed. Thus, data from this study suggest that the nutritional care protocols for patients with SCD should include dietary sources of selenium in order to reduce the risk of hemolysis.

1 February 2017 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
ABAdriana Costa Bacelo
Adriana Costa Bacelo
PBPedro Emmanuel Alvarenga Americano do Brasil
Pedro Emmanuel Alvarenga Americano do Brasil
CCCláudia dos Santos Cople-Rodrigues
Cláudia dos Santos Cople-Rodrigues
GIGeorg Ingebourg
Georg Ingebourg
EPEliane Paiva
Eliane Paiva
Valeria Cavalcanti RollaValeria Cavalcanti Rolla
Valeria Cavalcanti Rolla

12 March 2021 in European Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
JMJuliana Mendonca
Juliana Mendonca
CCCíntia Chaves Curioni
Cíntia Chaves Curioni
CCCláudia dos Santos Cople-Rodrigues
Cláudia dos Santos Cople-Rodrigues
MCMarta Citelli
Marta Citelli

1 May 2019 in Jornal de Pediatria
Verified
Journal Article
Open access
ISIsabel Nascimento dos Santos
Isabel Nascimento dos Santos
JDJorginete de Jesus Damião
Jorginete de Jesus Damião
MFMaria Fonseca
Maria Fonseca
CCCláudia dos Santos Cople-Rodrigues
Cláudia dos Santos Cople-Rodrigues
OAOdaleia Aguiar
Odaleia Aguiar
To examine the associations between food insecurity (IA) and social support in families of children with sickle-cell disease (DF). This cross-sectional study in families of 190 children from five to nine years old in follow-up at a hematology referral hospital in Rio de Janeiro State. IA was measured using the Brazilian food insecurity scale and social support was measured using the Brazilian version of the MOS social support survey instrument. The relation between IA and social support was analyzed by way of a multinomial logistic model. There was IA in 62.2% of the families, in moderate and severe form in, respectively, 11.1% and 7.9% of cases. In families of children with DF, levels of mild and severe food insecurity (IALe and IAGr) were found to relate inversely to levels of social support in the following dimensions: informational support (IALe OR=0.98; 95% CI 0.96-0.99 and IAGr OR=0.95; 95% CI 0.92-0.98); social interaction (IALe OR=0.98; 95% CI 0.96-0.99 and IAGr OR=0.96; 95% CI 0.93-0.99) and tangible social support (IALe OR=0.97; 95% CI 0.96-0.99 and IAGr OR=0.97; 95% CI 0.94-0.99). Considering the positive effects of social support on IA, public policies should be encouraged to assure food and nutritional security and social assistance for care for people with DF. Also, social support groups for people with DF should be strengthened.

5 May 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
MHMiguel Huang
Miguel Huang
CCCláudia dos Santos Cople-Rodrigues
Cláudia dos Santos Cople-Rodrigues
DWDan Linetzky Waitzberg
Dan Linetzky Waitzberg
IRIlanna Marques Gomes da Rocha
Ilanna Marques Gomes da Rocha
CCCíntia Chaves Curioni
Cíntia Chaves Curioni
Background: Herbal medicine is a low-cost treatment and has been increasingly applied in obesity treatment. Gut microbiota (GM) is strongly associated with obesity pathogenesis. Methods: We conducted a systematic review guided by the question: “Does the use of herbal medicine change the GM composition in obese individuals?” Randomized clinical trials with obese individuals assessing the effects of herbal medicine intervention in GM were retrieved from the Medline, Embase, Scopus, Web of Science, and Cochrane Library databases, including the Cochrane Controlled Trials Register. Two reviewers independently extracted data using standardized piloted data extraction forms and assessed the study-level risk of bias using an Excel template of the Cochrane “Risk of bias” tool 2—RoB 2. Results: We identified 1094 articles in the databases. After removing duplicates and reading the title and abstract, 14 publications were fully evaluated, of which seven publications from six studies were considered eligible. The herbs analyzed were Moringa oleifera, Punica granatum, Scutellaria baicalensis, Schisandra chinensis, W-LHIT and WCBE. The analysis showed that Schisandra chinensis and Scutellaria baicalensis had significant effects on weight loss herbal intervention therapy composed by five Chinese herbal medicines Ganoderma lucidum, Coptis chinensis, Astragalus membranaceus, Nelumbo nucifera gaertn, and Fructus aurantii (W-LHIT) and white common bean extract (WCBE) on GM, but no significant changes in anthropometry and laboratory biomarkers. Conclusions: Herbal medicine modulates GM and is associated with increased genera in obese individuals.